<DOC>
	<DOCNO>NCT02556814</DOCNO>
	<brief_summary>The project undertake Qilu Hospital Shandong University China . In order report efficacy safety caffeic acid tablet combine high-dose dexamethasone treatment adult newly-diagnosed primary immune thrombocytopenia ( ITP ) .</brief_summary>
	<brief_title>Caffeic Acid Combining High-dose Dexamethasone Management ITP</brief_title>
	<detailed_description>The investigator undertake multicenter , randomize , double blind placebo-controlled trial 240 primary ITP adult patient 8 medical center China . One part participant randomly select receive caffeic acid tablet ( give orally dose 900mg per day 3 consecutive month ) , combine dexamethasone ( give orally dose 40 mg per day 4 day , two cycle interval 10 day ) ; others select receive high-dose dexamethasone treatment plus placebo . Platelet count , bleed symptom evaluate treatment . Adverse event also record throughout study . In order report efficacy safety caffeic acid tablet combine high-dose dexamethasone therapy treatment adult ITP .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Caffeic acid</mesh_term>
	<criteria>1.Meet diagnostic criterion immune thrombocytopenia ; 2.Untreated hospitalize patient , may male female , age 18 ~ 80 year ; 3.To show platelet count &lt; 30 * 10^9/L , bleed manifestation ; 4.Willing able sign write informed consent 1.Received chemotherapy anticoagulant drug affect platelet count within 3 month screen visit 2.Received secondline ITPspecific treatment ( eg , cyclophosphamide , 6mercaptopurine , vincristine , vinblastine , etc ) within 3 month screen visit 3.Received highdose steroid IVIG 3 week prior start study 4.Current HIV infection hepatitis B virus hepatitis C virus infection 5.Severe medical condition ( lung , hepatic renal disorder ) chronic ITP . Unstable uncontrolled disease condition relate impacting cardiac function ( e.g. , unstable angina , congestive heart failure , uncontrolled hypertension cardiac arrhythmia ) 6.Female patient nurse pregnant , may pregnant , contemplate pregnancy study period 7.Have know diagnosis autoimmune disease , establish medical history laboratory finding positive result determination antinuclear antibody , anticardiolipin antibody , lupus anticoagulant direct Coombs test 8.Patients deem unsuitable study investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>ITP</keyword>
	<keyword>Caffeic Acid</keyword>
	<keyword>dexamethasone</keyword>
</DOC>